NIH-funded research Sbir 2 grant

Using low-dose magneto-thrombolysis to improve stroke treatment

Official title: Low-Dose Magneto-Thrombolysis to Expand Stroke Care

Funded at Unandup, LLC · NIH-10871913 · Data updated 2026-11-12

This study is testing a new way to help people who have had a stroke by using tiny particles to make the standard treatment work better and faster, so more patients can safely receive the care they need.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionUnandup, LLC
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startJuly 1, 2023
Project endJune 30, 2026
Funding year2024
Award (this year)$1,544,509
NIH project number5R44NS132605-02
Project IDNIH-10871913 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals experiencing acute ischemic stroke, particularly those who are currently ineligible for standard thrombolysis due to safety concerns.

Less likely to help

Patients with hemorrhagic strokes or those who do not have acute ischemic stroke will not benefit from this research.

What this research studies

This research investigates a new approach to treating acute ischemic stroke (AIS) by using a novel nanoparticle-based thrombolysis platform that enhances the effectiveness of the standard drug alteplase. The goal is to safely accelerate the drug's action, potentially allowing more patients to benefit from thrombolysis, especially those who currently do not qualify due to risks associated with higher doses. By improving the safety and efficacy of this treatment, the research aims to increase the number of AIS patients who can receive timely and effective care. The study will involve clinical trials to evaluate the outcomes of this innovative treatment method.

Why it matters

Potential benefit: If successful, this research could significantly improve stroke outcomes and increase the number of patients who can safely receive thrombolysis treatment.

How similar studies have gone: While thrombolysis is a well-established treatment, this specific approach using low-dose magneto-thrombolysis is novel and has not been extensively tested in prior studies.

Where this research is happening

  • Unandup, LLC
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Creighton, Francis Milton — Unandup, LLC
  • Study coordinator: Creighton, Francis Milton

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.